March 24, 2021
Article
Results from the phase 3 KEYNOTE-775/study 309 trial found that Keytruda plus Lenvima reduced risk of death by 38%, with a median overall survival of 18.3 months
March 23, 2021
The researchers analyzed body composition data from the National Health and Nutrition Examination Survey (1999-2004) and cardiovascular disease data from the National Health and Nutrition Examination Survey (1999-2014).
The company received Fast Track designation from the FDA for GEN-1, a DNA-mediated interleukin-12 (IL-12) immunotherapy.
Low doses of propylparaben–a chemical preservative found in food, drugs, and cosmetics–can alter pregnancy-related changes in the breast in ways that may lessen the protection against breast cancer normally conveyed by pregnancy hormones.
March 22, 2021
According to study results presented at the SGO meeting, biopsies showed no signs of cancer or precancer in two-thirds of 165 women with stage I endometrial cancer or atypical endometrial hyperplasia, 6 months after insertion of the hormonal IUD.
March 19, 2021
One recent study found COVID-19 antibodies in all 20 pregnant women and their newborns.
The study also found that women with chest pain were more likely than men to wait more than 12 hours before seeking medical help.
March 18, 2021
Additionally, the study revealed for the first time the physiological reason for the neutral protection is increased blood flow to the brain as a result of higher levels of progesterone.
March 17, 2021
Among more than 11 million Medicare beneficiaries who were admitted during the 2-year study period, there were 174,901 admitted for ischemic stroke and 193,418 admitted for heart attack.
March 16, 2021
In addition, oral contraceptives can also increase the risk of stroke in some women, especially those who smoke.
